Exforge copycats to hit markets

Published: 2013-02-25 07:00:00
Updated: 2013-02-25 07:00:00
The patent for Novartis’s Exforge, a drug with two most important ingredients for the treatment of hypertension, is set to expire early April in Korea so a swarm of generic versions can hit the market.

The release of generics is expected to give wider and easier access to treatment for people ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.